Updates are available Correction dated 2023-02-10
Click to view Correction: https://doi.org/10.1186/s13550-023-00961-y
-
Authors
Ambur Sankaranarayanan, Ramya
Florea, Alexandru
Allekotte, Susanne
Vogg, Andreas T. J.
Maurer, Jochen
Schäfer, Laura
Bolm, Carsten
Terhorst, Steven
Classen, Arno
Bauwens, Matthias
Morgenroth, Agnieszka
Mottaghy, Felix M. http://orcid.org/0000-0002-7212-6521
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (project number: 331065168 - GRK2375)
RWTH Aachen University
- License Information
-
More Information
Article History
Received: 2 May 2022
Accepted: 27 August 2022
First Online: 14 September 2022
Change Date: 10 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13550-023-00961-y
Declarations
:
: All animal experiments were approved by an accredited German ethical committee (Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) Nordrhein-Westfalen) for compliance with the Animal Protection Act, in conjunction with the regulation for the protection of animals used for experimental and other scientific purposes (file number 81-02.04.2018.A279). The study was carried out in compliance with the ARRIVE guidelines.
: Not applicable.
: FMM is medical advisor for NanoMab Technology Ltd. and Advanced Accelerator Applications (AAA) GmbH and has recently received institutional grants from NanoMab Technology Ltd., Siemens and GE Precision Healthcare LLC.
